Terri B. Sebree, President at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 3,800 shares at $5.79 ($22K) on 2018-08-06, disclosed to the SEC on 2018-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ZYNE | SELL | 2022-07-20 | $9K | — | Filing → |